Catenin Alpha-2 Mutation Changes the Immune Microenvironment in Lung Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitors
Background: Lung cancer has always been the most prevalent cancer. Lung adenocarcinoma (LUAD) is the most common lung cancer subtype and has a high tumor mutation rate. In addition to KRAS, EGFR, ALK, HER2, ROS1, and BRAF, which are known to have high mutation rates, we discovered some new mutated g...
Saved in:
Main Authors: | Yang Wen (Author), Anqi Lin (Author), Weiliang Zhu (Author), Ting Wei (Author), Peng Luo (Author), Linlang Guo (Author), Jian Zhang (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prognosis of Lung Adenocarcinoma Patients With NTRK3 Mutations to Immune Checkpoint Inhibitors
by: Yuchun Niu, et al.
Published: (2020) -
Mutations Status of Chemokine Signaling Pathway Predict Prognosis of Immune Checkpoint Inhibitors in Colon Adenocarcinoma
by: Anqi Lin, et al.
Published: (2021) -
Comprehensive analysis of Cuproplasia and immune microenvironment in lung adenocarcinoma
by: Junjie Kuang, et al.
Published: (2023) -
Genetic mutation profiles and immune microenvironment analysis of pulmonary enteric adenocarcinoma
by: Min Xie, et al.
Published: (2022) -
B Cell Receptor Signaling Pathway Mutation as Prognosis Predictor of Immune Checkpoint Inhibitors in Lung Adenocarcinoma by Bioinformatic Analysis
by: Lin A, et al.
Published: (2022)